Johann-Christoph Dettmann

Title: Johann-Christoph Dettmann: Innovator in Retroviral Vector Production

Introduction

Johann-Christoph Dettmann is a notable inventor based in Bergisch Gladbach, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of retroviral vector particles. His innovative work has implications for gene therapy and other medical applications.

Latest Patents

Dettmann holds a patent for an LDLR negative packaging cell line for the production of VSV-G pseudotyped retroviral vector particles. This invention provides a method for producing these vector particles, which are crucial for various therapeutic applications. The packaging cell line is designed to be negative for Low-Density Lipoprotein Receptor (LDLR) and may stably express VSV-G, enhancing the efficiency of vector production.

Career Highlights

Dettmann is associated with Miltenyi Biotec B.V. Co., KG, a company known for its advancements in cell and gene therapy technologies. His work at this organization has allowed him to focus on innovative solutions that address challenges in the production of viral vectors.

Collaborations

Throughout his career, Dettmann has collaborated with esteemed colleagues, including Martin Meyer and Ian Johnston. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biotechnology.

Conclusion

Johann-Christoph Dettmann's contributions to the field of retroviral vector production exemplify the importance of innovation in biotechnology. His patent and work at Miltenyi Biotec highlight his commitment to advancing medical science through effective solutions.